Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure (NCT04310787) | Clinical Trial Compass
RecruitingNot Applicable
Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure
China300 participantsStarted 2020-05-15
Plain-language summary
This study is to investigate the long-term outcomes and prognostic risk factors in patients recovered from hepatitis B virus related acute on-chronic liver failure.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age from 18 to 65 years old;
* The diagnosis consistent with hepatitis b associated chronic acute liver failureï¼›
* After hospitalization, the survival time \> 90 daysï¼›
* The inpatient clinical data are complete.
Exclusion Criteria:
* Human immunodeficiency virus infection or congenital immune deficiency diseases;
* Liver cancer and other tumors, autoimmune liver disease, genetic and metabolic liver disease, or other serious diseases that significantly affect patient survival;
* Other conditions that the researchers judged not appropriate for inclusion.
What they're measuring
1
adverse events
Timeframe: 5 years
Trial details
NCT IDNCT04310787
SponsorThird Affiliated Hospital, Sun Yat-Sen University